In Silico Discovery of Small-Molecule Inhibitors Targeting SARS-CoV-2 Main Protease

The COVID-19 pandemic has caused severe health threat globally, and novel SARS-Cov-2 inhibitors are urgently needed for antiviral treatment. The main protease (M(pro)) of the virus is one of the most effective and conserved targets for anti-SARS-CoV-2 drug development. In this study, we utilized a m...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Menghan, Kang, Dongwei, Liu, Na, Liu, Yanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383128/
https://www.ncbi.nlm.nih.gov/pubmed/37513194
http://dx.doi.org/10.3390/molecules28145320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383128/
https://www.ncbi.nlm.nih.gov/pubmed/37513194
http://dx.doi.org/10.3390/molecules28145320

Ejemplares similares